Baidu
map
CANCER CHEMOTH PHARM 润色咨询

CANCER CHEMOTHERAPY AND PHARMACOLOGY

出版年份：1978 年文章数：3635 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：3.3% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1088385, encodeId=4c2310883858a, content=评审要求我补充实验，可我的样品已经用完了/实验已经结束了，直接说我样本用完了会被拒稿么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150197, encodeId=e8d4215019edd, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：肿瘤;药理;化疗<br>经验分享：一篇小综述 第一次投稿三个星期了还是editor assigned，觉得太慢所以撤了稿。然后一直被其他的拒，所以后来又投这个。 第二次投稿 2023-05-17 submitted 2023-05-18 Reviewers Assigned（中途06-02变了时间） 2023-06-05 Under Review 2023-06-09 Reviewers Assigned（中途06-15，06-23，07-03，07-10变了时间） 2023-07-17 minor revision（给了十天小修时间，只有一个审稿人，编辑点了一下英语水平和摘要过于简短两处，我送去润了个色，23号返修回去了。然后因为格式有点问题，马上打回来了，24重新提交） 2023-07-24 Editor assigned 2023-07-27 Accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a75b8355868, createdName=ms3000002116358941, createdTime=Fri Jul 28 02:35:41 CST 2023, time=2023-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092071, encodeId=c1ff20920e159, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：癌症;药理<br>经验分享：一审很快，一周左右，小修一个半月，修回后半天就接受，效率杠杠的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3818221163, createdName=ms7000001575920827, createdTime=Thu Oct 06 13:40:45 CST 2022, time=2022-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218744, encodeId=88f51218e449f, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：肿瘤;化疗药<br>经验分享：8月底投稿，9月审稿意见补个小实验，11月再次提交然后一个星期内接收，12月底出版。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=19435556599, createdName=ms2000000730395477, createdTime=Wed May 11 14:51:09 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920655, encodeId=1fbc920655f0, content=审稿速度:3.0<br>偏重的研究方向：肿瘤;化疗<br>经验分享：请教一下大家，大修回去被拒的可能性大吗，按照审稿人意见修改的，审稿人意见挺好的，虽然给了大修，但是主要是修改讨论部分，大修意见也主要是提供一些审稿人自己的思路，我都加到讨论部分里面了，已经under review1周了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=559, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqSU0CLUujgLk4UUOR1ibG8ruibu1HpuH6icnUibmvdTBL2wVflfabqDQZWiaSe8zZ8gpchPXibGPcQotYw/132, createdBy=6c725325434, createdName=Y, createdTime=Thu Jan 28 10:04:30 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088386, encodeId=33d3108838606, content=评审和期刊编辑一般会询问什么问题？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586491, encodeId=22d15864910c, content=投稿后1个月给消息，小修后接受，按要求point to point回答了问题，润了色，现在返修半个多月了还是under review，估计是审稿人不满意，要凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca475278851, createdName=1483b36dm43(暂无昵称), createdTime=Fri Mar 13 00:40:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586490, encodeId=73b8586490a1, content=是美国的杂志不是德国的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca475278851, createdName=1483b36dm43(暂无昵称), createdTime=Fri Mar 13 00:36:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581076, encodeId=192c5810e6e7, content=online后多少时间正式发表<span class="quote">wind1060 2018-01-09 21:01:00 发表:<br>杂志不选open access的话不要版面费，编辑比较友好，审稿人的意见很专业，投的一篇文章一审用了两个月，给1个半月补实验修稿，补了一个实验，按照要求认真回答了问题，修回后又审了半个月接收了。接收后半个月左右收到proof，给2个工作日的时间proof，返回proof后第二天就online了，总体来说效率还是挺高的，德国人也确实挺负责。祝大家好运！</span>, beContent=wind1060 2018-01-09 21:01:00 发表: 杂志不选open access的话不要版面费，编辑比较友好，审稿人的意见很专业，投的一篇文章一审用了两个月，给1个半月补实验修稿，补了一个实验，按照要求认真回答了问题，修回后又审了半个月接收了。接收后半个月左右收到proof，给2个工作日的时间proof，返回proof后第二天就online了，总体来说效率还是挺高的，德国人也确实挺负责。祝大家好运！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=14e11602765, createdName=sxmlw, createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572522, encodeId=5d685e2522f0, content=哈哈 突破3分了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e641638819, createdName=eathon, createdTime=Thu Jun 20 21:32:00 CST 2019, time=2019-06-20, status=1, ipAttribution=)]
    2021-12-28 MS54455111222

    评审要求我补充实验，可我的样品已经用完了/实验已经结束了，直接说我样本用完了会被拒稿么？

    4

    展开4条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1088385, encodeId=4c2310883858a, content=评审要求我补充实验，可我的样品已经用完了/实验已经结束了，直接说我样本用完了会被拒稿么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150197, encodeId=e8d4215019edd, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：肿瘤;药理;化疗<br>经验分享：一篇小综述 第一次投稿三个星期了还是editor assigned，觉得太慢所以撤了稿。然后一直被其他的拒，所以后来又投这个。 第二次投稿 2023-05-17 submitted 2023-05-18 Reviewers Assigned（中途06-02变了时间） 2023-06-05 Under Review 2023-06-09 Reviewers Assigned（中途06-15，06-23，07-03，07-10变了时间） 2023-07-17 minor revision（给了十天小修时间，只有一个审稿人，编辑点了一下英语水平和摘要过于简短两处，我送去润了个色，23号返修回去了。然后因为格式有点问题，马上打回来了，24重新提交） 2023-07-24 Editor assigned 2023-07-27 Accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a75b8355868, createdName=ms3000002116358941, createdTime=Fri Jul 28 02:35:41 CST 2023, time=2023-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092071, encodeId=c1ff20920e159, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：癌症;药理<br>经验分享：一审很快，一周左右，小修一个半月，修回后半天就接受，效率杠杠的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3818221163, createdName=ms7000001575920827, createdTime=Thu Oct 06 13:40:45 CST 2022, time=2022-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218744, encodeId=88f51218e449f, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：肿瘤;化疗药<br>经验分享：8月底投稿，9月审稿意见补个小实验，11月再次提交然后一个星期内接收，12月底出版。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=19435556599, createdName=ms2000000730395477, createdTime=Wed May 11 14:51:09 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920655, encodeId=1fbc920655f0, content=审稿速度:3.0<br>偏重的研究方向：肿瘤;化疗<br>经验分享：请教一下大家，大修回去被拒的可能性大吗，按照审稿人意见修改的，审稿人意见挺好的，虽然给了大修，但是主要是修改讨论部分，大修意见也主要是提供一些审稿人自己的思路，我都加到讨论部分里面了，已经under review1周了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=559, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqSU0CLUujgLk4UUOR1ibG8ruibu1HpuH6icnUibmvdTBL2wVflfabqDQZWiaSe8zZ8gpchPXibGPcQotYw/132, createdBy=6c725325434, createdName=Y, createdTime=Thu Jan 28 10:04:30 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088386, encodeId=33d3108838606, content=评审和期刊编辑一般会询问什么问题？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586491, encodeId=22d15864910c, content=投稿后1个月给消息，小修后接受，按要求point to point回答了问题，润了色，现在返修半个多月了还是under review，估计是审稿人不满意，要凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca475278851, createdName=1483b36dm43(暂无昵称), createdTime=Fri Mar 13 00:40:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586490, encodeId=73b8586490a1, content=是美国的杂志不是德国的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca475278851, createdName=1483b36dm43(暂无昵称), createdTime=Fri Mar 13 00:36:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581076, encodeId=192c5810e6e7, content=online后多少时间正式发表<span class="quote">wind1060 2018-01-09 21:01:00 发表:<br>杂志不选open access的话不要版面费，编辑比较友好，审稿人的意见很专业，投的一篇文章一审用了两个月，给1个半月补实验修稿，补了一个实验，按照要求认真回答了问题，修回后又审了半个月接收了。接收后半个月左右收到proof，给2个工作日的时间proof，返回proof后第二天就online了，总体来说效率还是挺高的，德国人也确实挺负责。祝大家好运！</span>, beContent=wind1060 2018-01-09 21:01:00 发表: 杂志不选open access的话不要版面费，编辑比较友好，审稿人的意见很专业，投的一篇文章一审用了两个月，给1个半月补实验修稿，补了一个实验，按照要求认真回答了问题，修回后又审了半个月接收了。接收后半个月左右收到proof，给2个工作日的时间proof，返回proof后第二天就online了，总体来说效率还是挺高的，德国人也确实挺负责。祝大家好运！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=14e11602765, createdName=sxmlw, createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572522, encodeId=5d685e2522f0, content=哈哈 突破3分了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e641638819, createdName=eathon, createdTime=Thu Jun 20 21:32:00 CST 2019, time=2019-06-20, status=1, ipAttribution=)]
    2023-07-28 ms3000002116358941

    审稿速度:2.0 | 投稿命中率:75.0
    偏重的研究方向：肿瘤;药理;化疗
    经验分享：一篇小综述 第一次投稿三个星期了还是editor assigned，觉得太慢所以撤了稿。然后一直被其他的拒，所以后来又投这个。 第二次投稿 2023-05-17 submitted 2023-05-18 Reviewers Assigned（中途06-02变了时间） 2023-06-05 Under Review 2023-06-09 Reviewers Assigned（中途06-15，06-23，07-03，07-10变了时间） 2023-07-17 minor revision（给了十天小修时间，只有一个审稿人，编辑点了一下英语水平和摘要过于简短两处，我送去润了个色，23号返修回去了。然后因为格式有点问题，马上打回来了，24重新提交） 2023-07-24 Editor assigned 2023-07-27 Accept

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1088385, encodeId=4c2310883858a, content=评审要求我补充实验，可我的样品已经用完了/实验已经结束了，直接说我样本用完了会被拒稿么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150197, encodeId=e8d4215019edd, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：肿瘤;药理;化疗<br>经验分享：一篇小综述 第一次投稿三个星期了还是editor assigned，觉得太慢所以撤了稿。然后一直被其他的拒，所以后来又投这个。 第二次投稿 2023-05-17 submitted 2023-05-18 Reviewers Assigned（中途06-02变了时间） 2023-06-05 Under Review 2023-06-09 Reviewers Assigned（中途06-15，06-23，07-03，07-10变了时间） 2023-07-17 minor revision（给了十天小修时间，只有一个审稿人，编辑点了一下英语水平和摘要过于简短两处，我送去润了个色，23号返修回去了。然后因为格式有点问题，马上打回来了，24重新提交） 2023-07-24 Editor assigned 2023-07-27 Accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a75b8355868, createdName=ms3000002116358941, createdTime=Fri Jul 28 02:35:41 CST 2023, time=2023-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092071, encodeId=c1ff20920e159, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：癌症;药理<br>经验分享：一审很快，一周左右，小修一个半月，修回后半天就接受，效率杠杠的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3818221163, createdName=ms7000001575920827, createdTime=Thu Oct 06 13:40:45 CST 2022, time=2022-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218744, encodeId=88f51218e449f, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：肿瘤;化疗药<br>经验分享：8月底投稿，9月审稿意见补个小实验，11月再次提交然后一个星期内接收，12月底出版。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=19435556599, createdName=ms2000000730395477, createdTime=Wed May 11 14:51:09 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920655, encodeId=1fbc920655f0, content=审稿速度:3.0<br>偏重的研究方向：肿瘤;化疗<br>经验分享：请教一下大家，大修回去被拒的可能性大吗，按照审稿人意见修改的，审稿人意见挺好的，虽然给了大修，但是主要是修改讨论部分，大修意见也主要是提供一些审稿人自己的思路，我都加到讨论部分里面了，已经under review1周了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=559, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqSU0CLUujgLk4UUOR1ibG8ruibu1HpuH6icnUibmvdTBL2wVflfabqDQZWiaSe8zZ8gpchPXibGPcQotYw/132, createdBy=6c725325434, createdName=Y, createdTime=Thu Jan 28 10:04:30 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088386, encodeId=33d3108838606, content=评审和期刊编辑一般会询问什么问题？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586491, encodeId=22d15864910c, content=投稿后1个月给消息，小修后接受，按要求point to point回答了问题，润了色，现在返修半个多月了还是under review，估计是审稿人不满意，要凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca475278851, createdName=1483b36dm43(暂无昵称), createdTime=Fri Mar 13 00:40:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586490, encodeId=73b8586490a1, content=是美国的杂志不是德国的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca475278851, createdName=1483b36dm43(暂无昵称), createdTime=Fri Mar 13 00:36:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581076, encodeId=192c5810e6e7, content=online后多少时间正式发表<span class="quote">wind1060 2018-01-09 21:01:00 发表:<br>杂志不选open access的话不要版面费，编辑比较友好，审稿人的意见很专业，投的一篇文章一审用了两个月，给1个半月补实验修稿，补了一个实验，按照要求认真回答了问题，修回后又审了半个月接收了。接收后半个月左右收到proof，给2个工作日的时间proof，返回proof后第二天就online了，总体来说效率还是挺高的，德国人也确实挺负责。祝大家好运！</span>, beContent=wind1060 2018-01-09 21:01:00 发表: 杂志不选open access的话不要版面费，编辑比较友好，审稿人的意见很专业，投的一篇文章一审用了两个月，给1个半月补实验修稿，补了一个实验，按照要求认真回答了问题，修回后又审了半个月接收了。接收后半个月左右收到proof，给2个工作日的时间proof，返回proof后第二天就online了，总体来说效率还是挺高的，德国人也确实挺负责。祝大家好运！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=14e11602765, createdName=sxmlw, createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572522, encodeId=5d685e2522f0, content=哈哈 突破3分了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e641638819, createdName=eathon, createdTime=Thu Jun 20 21:32:00 CST 2019, time=2019-06-20, status=1, ipAttribution=)]
    2022-10-06 ms7000001575920827

    审稿速度:3.0 | 投稿命中率:50.0
    偏重的研究方向：癌症;药理
    经验分享：一审很快，一周左右，小修一个半月，修回后半天就接受，效率杠杠的

    5

    展开5条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1088385, encodeId=4c2310883858a, content=评审要求我补充实验，可我的样品已经用完了/实验已经结束了，直接说我样本用完了会被拒稿么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150197, encodeId=e8d4215019edd, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：肿瘤;药理;化疗<br>经验分享：一篇小综述 第一次投稿三个星期了还是editor assigned，觉得太慢所以撤了稿。然后一直被其他的拒，所以后来又投这个。 第二次投稿 2023-05-17 submitted 2023-05-18 Reviewers Assigned（中途06-02变了时间） 2023-06-05 Under Review 2023-06-09 Reviewers Assigned（中途06-15，06-23，07-03，07-10变了时间） 2023-07-17 minor revision（给了十天小修时间，只有一个审稿人，编辑点了一下英语水平和摘要过于简短两处，我送去润了个色，23号返修回去了。然后因为格式有点问题，马上打回来了，24重新提交） 2023-07-24 Editor assigned 2023-07-27 Accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a75b8355868, createdName=ms3000002116358941, createdTime=Fri Jul 28 02:35:41 CST 2023, time=2023-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092071, encodeId=c1ff20920e159, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：癌症;药理<br>经验分享：一审很快，一周左右，小修一个半月，修回后半天就接受，效率杠杠的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3818221163, createdName=ms7000001575920827, createdTime=Thu Oct 06 13:40:45 CST 2022, time=2022-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218744, encodeId=88f51218e449f, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：肿瘤;化疗药<br>经验分享：8月底投稿，9月审稿意见补个小实验，11月再次提交然后一个星期内接收，12月底出版。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=19435556599, createdName=ms2000000730395477, createdTime=Wed May 11 14:51:09 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920655, encodeId=1fbc920655f0, content=审稿速度:3.0<br>偏重的研究方向：肿瘤;化疗<br>经验分享：请教一下大家，大修回去被拒的可能性大吗，按照审稿人意见修改的，审稿人意见挺好的，虽然给了大修，但是主要是修改讨论部分，大修意见也主要是提供一些审稿人自己的思路，我都加到讨论部分里面了，已经under review1周了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=559, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqSU0CLUujgLk4UUOR1ibG8ruibu1HpuH6icnUibmvdTBL2wVflfabqDQZWiaSe8zZ8gpchPXibGPcQotYw/132, createdBy=6c725325434, createdName=Y, createdTime=Thu Jan 28 10:04:30 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088386, encodeId=33d3108838606, content=评审和期刊编辑一般会询问什么问题？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586491, encodeId=22d15864910c, content=投稿后1个月给消息，小修后接受，按要求point to point回答了问题，润了色，现在返修半个多月了还是under review，估计是审稿人不满意，要凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca475278851, createdName=1483b36dm43(暂无昵称), createdTime=Fri Mar 13 00:40:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586490, encodeId=73b8586490a1, content=是美国的杂志不是德国的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca475278851, createdName=1483b36dm43(暂无昵称), createdTime=Fri Mar 13 00:36:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581076, encodeId=192c5810e6e7, content=online后多少时间正式发表<span class="quote">wind1060 2018-01-09 21:01:00 发表:<br>杂志不选open access的话不要版面费，编辑比较友好，审稿人的意见很专业，投的一篇文章一审用了两个月，给1个半月补实验修稿，补了一个实验，按照要求认真回答了问题，修回后又审了半个月接收了。接收后半个月左右收到proof，给2个工作日的时间proof，返回proof后第二天就online了，总体来说效率还是挺高的，德国人也确实挺负责。祝大家好运！</span>, beContent=wind1060 2018-01-09 21:01:00 发表: 杂志不选open access的话不要版面费，编辑比较友好，审稿人的意见很专业，投的一篇文章一审用了两个月，给1个半月补实验修稿，补了一个实验，按照要求认真回答了问题，修回后又审了半个月接收了。接收后半个月左右收到proof，给2个工作日的时间proof，返回proof后第二天就online了，总体来说效率还是挺高的，德国人也确实挺负责。祝大家好运！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=14e11602765, createdName=sxmlw, createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572522, encodeId=5d685e2522f0, content=哈哈 突破3分了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e641638819, createdName=eathon, createdTime=Thu Jun 20 21:32:00 CST 2019, time=2019-06-20, status=1, ipAttribution=)]
    2022-05-11 ms2000000730395477

    审稿速度:1.0 | 投稿命中率:75.0
    偏重的研究方向：肿瘤;化疗药
    经验分享：8月底投稿，9月审稿意见补个小实验，11月再次提交然后一个星期内接收，12月底出版。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1088385, encodeId=4c2310883858a, content=评审要求我补充实验，可我的样品已经用完了/实验已经结束了，直接说我样本用完了会被拒稿么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150197, encodeId=e8d4215019edd, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：肿瘤;药理;化疗<br>经验分享：一篇小综述 第一次投稿三个星期了还是editor assigned，觉得太慢所以撤了稿。然后一直被其他的拒，所以后来又投这个。 第二次投稿 2023-05-17 submitted 2023-05-18 Reviewers Assigned（中途06-02变了时间） 2023-06-05 Under Review 2023-06-09 Reviewers Assigned（中途06-15，06-23，07-03，07-10变了时间） 2023-07-17 minor revision（给了十天小修时间，只有一个审稿人，编辑点了一下英语水平和摘要过于简短两处，我送去润了个色，23号返修回去了。然后因为格式有点问题，马上打回来了，24重新提交） 2023-07-24 Editor assigned 2023-07-27 Accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a75b8355868, createdName=ms3000002116358941, createdTime=Fri Jul 28 02:35:41 CST 2023, time=2023-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092071, encodeId=c1ff20920e159, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：癌症;药理<br>经验分享：一审很快，一周左右，小修一个半月，修回后半天就接受，效率杠杠的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3818221163, createdName=ms7000001575920827, createdTime=Thu Oct 06 13:40:45 CST 2022, time=2022-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218744, encodeId=88f51218e449f, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：肿瘤;化疗药<br>经验分享：8月底投稿，9月审稿意见补个小实验，11月再次提交然后一个星期内接收，12月底出版。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=19435556599, createdName=ms2000000730395477, createdTime=Wed May 11 14:51:09 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920655, encodeId=1fbc920655f0, content=审稿速度:3.0<br>偏重的研究方向：肿瘤;化疗<br>经验分享：请教一下大家，大修回去被拒的可能性大吗，按照审稿人意见修改的，审稿人意见挺好的，虽然给了大修，但是主要是修改讨论部分，大修意见也主要是提供一些审稿人自己的思路，我都加到讨论部分里面了，已经under review1周了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=559, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqSU0CLUujgLk4UUOR1ibG8ruibu1HpuH6icnUibmvdTBL2wVflfabqDQZWiaSe8zZ8gpchPXibGPcQotYw/132, createdBy=6c725325434, createdName=Y, createdTime=Thu Jan 28 10:04:30 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088386, encodeId=33d3108838606, content=评审和期刊编辑一般会询问什么问题？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586491, encodeId=22d15864910c, content=投稿后1个月给消息，小修后接受，按要求point to point回答了问题，润了色，现在返修半个多月了还是under review，估计是审稿人不满意，要凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca475278851, createdName=1483b36dm43(暂无昵称), createdTime=Fri Mar 13 00:40:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586490, encodeId=73b8586490a1, content=是美国的杂志不是德国的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca475278851, createdName=1483b36dm43(暂无昵称), createdTime=Fri Mar 13 00:36:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581076, encodeId=192c5810e6e7, content=online后多少时间正式发表<span class="quote">wind1060 2018-01-09 21:01:00 发表:<br>杂志不选open access的话不要版面费，编辑比较友好，审稿人的意见很专业，投的一篇文章一审用了两个月，给1个半月补实验修稿，补了一个实验，按照要求认真回答了问题，修回后又审了半个月接收了。接收后半个月左右收到proof，给2个工作日的时间proof，返回proof后第二天就online了，总体来说效率还是挺高的，德国人也确实挺负责。祝大家好运！</span>, beContent=wind1060 2018-01-09 21:01:00 发表: 杂志不选open access的话不要版面费，编辑比较友好，审稿人的意见很专业，投的一篇文章一审用了两个月，给1个半月补实验修稿，补了一个实验，按照要求认真回答了问题，修回后又审了半个月接收了。接收后半个月左右收到proof，给2个工作日的时间proof，返回proof后第二天就online了，总体来说效率还是挺高的，德国人也确实挺负责。祝大家好运！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=14e11602765, createdName=sxmlw, createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572522, encodeId=5d685e2522f0, content=哈哈 突破3分了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e641638819, createdName=eathon, createdTime=Thu Jun 20 21:32:00 CST 2019, time=2019-06-20, status=1, ipAttribution=)]
    2021-01-28 Y

    审稿速度:3.0
    偏重的研究方向：肿瘤;化疗
    经验分享：请教一下大家，大修回去被拒的可能性大吗，按照审稿人意见修改的，审稿人意见挺好的，虽然给了大修，但是主要是修改讨论部分，大修意见也主要是提供一些审稿人自己的思路，我都加到讨论部分里面了，已经under review1周了。

    2

    展开2条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=1088385, encodeId=4c2310883858a, content=评审要求我补充实验，可我的样品已经用完了/实验已经结束了，直接说我样本用完了会被拒稿么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150197, encodeId=e8d4215019edd, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：肿瘤;药理;化疗<br>经验分享：一篇小综述 第一次投稿三个星期了还是editor assigned，觉得太慢所以撤了稿。然后一直被其他的拒，所以后来又投这个。 第二次投稿 2023-05-17 submitted 2023-05-18 Reviewers Assigned（中途06-02变了时间） 2023-06-05 Under Review 2023-06-09 Reviewers Assigned（中途06-15，06-23，07-03，07-10变了时间） 2023-07-17 minor revision（给了十天小修时间，只有一个审稿人，编辑点了一下英语水平和摘要过于简短两处，我送去润了个色，23号返修回去了。然后因为格式有点问题，马上打回来了，24重新提交） 2023-07-24 Editor assigned 2023-07-27 Accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a75b8355868, createdName=ms3000002116358941, createdTime=Fri Jul 28 02:35:41 CST 2023, time=2023-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092071, encodeId=c1ff20920e159, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：癌症;药理<br>经验分享：一审很快，一周左右，小修一个半月，修回后半天就接受，效率杠杠的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3818221163, createdName=ms7000001575920827, createdTime=Thu Oct 06 13:40:45 CST 2022, time=2022-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218744, encodeId=88f51218e449f, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：肿瘤;化疗药<br>经验分享：8月底投稿，9月审稿意见补个小实验，11月再次提交然后一个星期内接收，12月底出版。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=19435556599, createdName=ms2000000730395477, createdTime=Wed May 11 14:51:09 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920655, encodeId=1fbc920655f0, content=审稿速度:3.0<br>偏重的研究方向：肿瘤;化疗<br>经验分享：请教一下大家，大修回去被拒的可能性大吗，按照审稿人意见修改的，审稿人意见挺好的，虽然给了大修，但是主要是修改讨论部分，大修意见也主要是提供一些审稿人自己的思路，我都加到讨论部分里面了，已经under review1周了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=559, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqSU0CLUujgLk4UUOR1ibG8ruibu1HpuH6icnUibmvdTBL2wVflfabqDQZWiaSe8zZ8gpchPXibGPcQotYw/132, createdBy=6c725325434, createdName=Y, createdTime=Thu Jan 28 10:04:30 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088386, encodeId=33d3108838606, content=评审和期刊编辑一般会询问什么问题？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586491, encodeId=22d15864910c, content=投稿后1个月给消息，小修后接受，按要求point to point回答了问题，润了色，现在返修半个多月了还是under review，估计是审稿人不满意，要凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca475278851, createdName=1483b36dm43(暂无昵称), createdTime=Fri Mar 13 00:40:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586490, encodeId=73b8586490a1, content=是美国的杂志不是德国的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca475278851, createdName=1483b36dm43(暂无昵称), createdTime=Fri Mar 13 00:36:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581076, encodeId=192c5810e6e7, content=online后多少时间正式发表<span class="quote">wind1060 2018-01-09 21:01:00 发表:<br>杂志不选open access的话不要版面费，编辑比较友好，审稿人的意见很专业，投的一篇文章一审用了两个月，给1个半月补实验修稿，补了一个实验，按照要求认真回答了问题，修回后又审了半个月接收了。接收后半个月左右收到proof，给2个工作日的时间proof，返回proof后第二天就online了，总体来说效率还是挺高的，德国人也确实挺负责。祝大家好运！</span>, beContent=wind1060 2018-01-09 21:01:00 发表: 杂志不选open access的话不要版面费，编辑比较友好，审稿人的意见很专业，投的一篇文章一审用了两个月，给1个半月补实验修稿，补了一个实验，按照要求认真回答了问题，修回后又审了半个月接收了。接收后半个月左右收到proof，给2个工作日的时间proof，返回proof后第二天就online了，总体来说效率还是挺高的，德国人也确实挺负责。祝大家好运！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=14e11602765, createdName=sxmlw, createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572522, encodeId=5d685e2522f0, content=哈哈 突破3分了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e641638819, createdName=eathon, createdTime=Thu Jun 20 21:32:00 CST 2019, time=2019-06-20, status=1, ipAttribution=)]
    2021-12-28 Gym璨烨

    评审和期刊编辑一般会询问什么问题？

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=1088385, encodeId=4c2310883858a, content=评审要求我补充实验，可我的样品已经用完了/实验已经结束了，直接说我样本用完了会被拒稿么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150197, encodeId=e8d4215019edd, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：肿瘤;药理;化疗<br>经验分享：一篇小综述 第一次投稿三个星期了还是editor assigned，觉得太慢所以撤了稿。然后一直被其他的拒，所以后来又投这个。 第二次投稿 2023-05-17 submitted 2023-05-18 Reviewers Assigned（中途06-02变了时间） 2023-06-05 Under Review 2023-06-09 Reviewers Assigned（中途06-15，06-23，07-03，07-10变了时间） 2023-07-17 minor revision（给了十天小修时间，只有一个审稿人，编辑点了一下英语水平和摘要过于简短两处，我送去润了个色，23号返修回去了。然后因为格式有点问题，马上打回来了，24重新提交） 2023-07-24 Editor assigned 2023-07-27 Accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a75b8355868, createdName=ms3000002116358941, createdTime=Fri Jul 28 02:35:41 CST 2023, time=2023-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092071, encodeId=c1ff20920e159, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：癌症;药理<br>经验分享：一审很快，一周左右，小修一个半月，修回后半天就接受，效率杠杠的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3818221163, createdName=ms7000001575920827, createdTime=Thu Oct 06 13:40:45 CST 2022, time=2022-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218744, encodeId=88f51218e449f, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：肿瘤;化疗药<br>经验分享：8月底投稿，9月审稿意见补个小实验，11月再次提交然后一个星期内接收，12月底出版。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=19435556599, createdName=ms2000000730395477, createdTime=Wed May 11 14:51:09 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920655, encodeId=1fbc920655f0, content=审稿速度:3.0<br>偏重的研究方向：肿瘤;化疗<br>经验分享：请教一下大家，大修回去被拒的可能性大吗，按照审稿人意见修改的，审稿人意见挺好的，虽然给了大修，但是主要是修改讨论部分，大修意见也主要是提供一些审稿人自己的思路，我都加到讨论部分里面了，已经under review1周了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=559, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqSU0CLUujgLk4UUOR1ibG8ruibu1HpuH6icnUibmvdTBL2wVflfabqDQZWiaSe8zZ8gpchPXibGPcQotYw/132, createdBy=6c725325434, createdName=Y, createdTime=Thu Jan 28 10:04:30 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088386, encodeId=33d3108838606, content=评审和期刊编辑一般会询问什么问题？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586491, encodeId=22d15864910c, content=投稿后1个月给消息，小修后接受，按要求point to point回答了问题，润了色，现在返修半个多月了还是under review，估计是审稿人不满意，要凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca475278851, createdName=1483b36dm43(暂无昵称), createdTime=Fri Mar 13 00:40:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586490, encodeId=73b8586490a1, content=是美国的杂志不是德国的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca475278851, createdName=1483b36dm43(暂无昵称), createdTime=Fri Mar 13 00:36:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581076, encodeId=192c5810e6e7, content=online后多少时间正式发表<span class="quote">wind1060 2018-01-09 21:01:00 发表:<br>杂志不选open access的话不要版面费，编辑比较友好，审稿人的意见很专业，投的一篇文章一审用了两个月，给1个半月补实验修稿，补了一个实验，按照要求认真回答了问题，修回后又审了半个月接收了。接收后半个月左右收到proof，给2个工作日的时间proof，返回proof后第二天就online了，总体来说效率还是挺高的，德国人也确实挺负责。祝大家好运！</span>, beContent=wind1060 2018-01-09 21:01:00 发表: 杂志不选open access的话不要版面费，编辑比较友好，审稿人的意见很专业，投的一篇文章一审用了两个月，给1个半月补实验修稿，补了一个实验，按照要求认真回答了问题，修回后又审了半个月接收了。接收后半个月左右收到proof，给2个工作日的时间proof，返回proof后第二天就online了，总体来说效率还是挺高的，德国人也确实挺负责。祝大家好运！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=14e11602765, createdName=sxmlw, createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572522, encodeId=5d685e2522f0, content=哈哈 突破3分了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e641638819, createdName=eathon, createdTime=Thu Jun 20 21:32:00 CST 2019, time=2019-06-20, status=1, ipAttribution=)]
    2020-03-13 1483b36dm43(暂无昵称)

    投稿后1个月给消息，小修后接受，按要求point to point回答了问题，润了色，现在返修半个多月了还是under review，估计是审稿人不满意，要凉了

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=1088385, encodeId=4c2310883858a, content=评审要求我补充实验，可我的样品已经用完了/实验已经结束了，直接说我样本用完了会被拒稿么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150197, encodeId=e8d4215019edd, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：肿瘤;药理;化疗<br>经验分享：一篇小综述 第一次投稿三个星期了还是editor assigned，觉得太慢所以撤了稿。然后一直被其他的拒，所以后来又投这个。 第二次投稿 2023-05-17 submitted 2023-05-18 Reviewers Assigned（中途06-02变了时间） 2023-06-05 Under Review 2023-06-09 Reviewers Assigned（中途06-15，06-23，07-03，07-10变了时间） 2023-07-17 minor revision（给了十天小修时间，只有一个审稿人，编辑点了一下英语水平和摘要过于简短两处，我送去润了个色，23号返修回去了。然后因为格式有点问题，马上打回来了，24重新提交） 2023-07-24 Editor assigned 2023-07-27 Accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a75b8355868, createdName=ms3000002116358941, createdTime=Fri Jul 28 02:35:41 CST 2023, time=2023-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092071, encodeId=c1ff20920e159, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：癌症;药理<br>经验分享：一审很快，一周左右，小修一个半月，修回后半天就接受，效率杠杠的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3818221163, createdName=ms7000001575920827, createdTime=Thu Oct 06 13:40:45 CST 2022, time=2022-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218744, encodeId=88f51218e449f, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：肿瘤;化疗药<br>经验分享：8月底投稿，9月审稿意见补个小实验，11月再次提交然后一个星期内接收，12月底出版。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=19435556599, createdName=ms2000000730395477, createdTime=Wed May 11 14:51:09 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920655, encodeId=1fbc920655f0, content=审稿速度:3.0<br>偏重的研究方向：肿瘤;化疗<br>经验分享：请教一下大家，大修回去被拒的可能性大吗，按照审稿人意见修改的，审稿人意见挺好的，虽然给了大修，但是主要是修改讨论部分，大修意见也主要是提供一些审稿人自己的思路，我都加到讨论部分里面了，已经under review1周了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=559, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqSU0CLUujgLk4UUOR1ibG8ruibu1HpuH6icnUibmvdTBL2wVflfabqDQZWiaSe8zZ8gpchPXibGPcQotYw/132, createdBy=6c725325434, createdName=Y, createdTime=Thu Jan 28 10:04:30 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088386, encodeId=33d3108838606, content=评审和期刊编辑一般会询问什么问题？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586491, encodeId=22d15864910c, content=投稿后1个月给消息，小修后接受，按要求point to point回答了问题，润了色，现在返修半个多月了还是under review，估计是审稿人不满意，要凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca475278851, createdName=1483b36dm43(暂无昵称), createdTime=Fri Mar 13 00:40:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586490, encodeId=73b8586490a1, content=是美国的杂志不是德国的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca475278851, createdName=1483b36dm43(暂无昵称), createdTime=Fri Mar 13 00:36:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581076, encodeId=192c5810e6e7, content=online后多少时间正式发表<span class="quote">wind1060 2018-01-09 21:01:00 发表:<br>杂志不选open access的话不要版面费，编辑比较友好，审稿人的意见很专业，投的一篇文章一审用了两个月，给1个半月补实验修稿，补了一个实验，按照要求认真回答了问题，修回后又审了半个月接收了。接收后半个月左右收到proof，给2个工作日的时间proof，返回proof后第二天就online了，总体来说效率还是挺高的，德国人也确实挺负责。祝大家好运！</span>, beContent=wind1060 2018-01-09 21:01:00 发表: 杂志不选open access的话不要版面费，编辑比较友好，审稿人的意见很专业，投的一篇文章一审用了两个月，给1个半月补实验修稿，补了一个实验，按照要求认真回答了问题，修回后又审了半个月接收了。接收后半个月左右收到proof，给2个工作日的时间proof，返回proof后第二天就online了，总体来说效率还是挺高的，德国人也确实挺负责。祝大家好运！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=14e11602765, createdName=sxmlw, createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572522, encodeId=5d685e2522f0, content=哈哈 突破3分了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e641638819, createdName=eathon, createdTime=Thu Jun 20 21:32:00 CST 2019, time=2019-06-20, status=1, ipAttribution=)]
    2020-03-13 1483b36dm43(暂无昵称)

    是美国的杂志不是德国的

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1088385, encodeId=4c2310883858a, content=评审要求我补充实验，可我的样品已经用完了/实验已经结束了，直接说我样本用完了会被拒稿么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150197, encodeId=e8d4215019edd, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：肿瘤;药理;化疗<br>经验分享：一篇小综述 第一次投稿三个星期了还是editor assigned，觉得太慢所以撤了稿。然后一直被其他的拒，所以后来又投这个。 第二次投稿 2023-05-17 submitted 2023-05-18 Reviewers Assigned（中途06-02变了时间） 2023-06-05 Under Review 2023-06-09 Reviewers Assigned（中途06-15，06-23，07-03，07-10变了时间） 2023-07-17 minor revision（给了十天小修时间，只有一个审稿人，编辑点了一下英语水平和摘要过于简短两处，我送去润了个色，23号返修回去了。然后因为格式有点问题，马上打回来了，24重新提交） 2023-07-24 Editor assigned 2023-07-27 Accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a75b8355868, createdName=ms3000002116358941, createdTime=Fri Jul 28 02:35:41 CST 2023, time=2023-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092071, encodeId=c1ff20920e159, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：癌症;药理<br>经验分享：一审很快，一周左右，小修一个半月，修回后半天就接受，效率杠杠的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3818221163, createdName=ms7000001575920827, createdTime=Thu Oct 06 13:40:45 CST 2022, time=2022-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218744, encodeId=88f51218e449f, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：肿瘤;化疗药<br>经验分享：8月底投稿，9月审稿意见补个小实验，11月再次提交然后一个星期内接收，12月底出版。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=19435556599, createdName=ms2000000730395477, createdTime=Wed May 11 14:51:09 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920655, encodeId=1fbc920655f0, content=审稿速度:3.0<br>偏重的研究方向：肿瘤;化疗<br>经验分享：请教一下大家，大修回去被拒的可能性大吗，按照审稿人意见修改的，审稿人意见挺好的，虽然给了大修，但是主要是修改讨论部分，大修意见也主要是提供一些审稿人自己的思路，我都加到讨论部分里面了，已经under review1周了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=559, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqSU0CLUujgLk4UUOR1ibG8ruibu1HpuH6icnUibmvdTBL2wVflfabqDQZWiaSe8zZ8gpchPXibGPcQotYw/132, createdBy=6c725325434, createdName=Y, createdTime=Thu Jan 28 10:04:30 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088386, encodeId=33d3108838606, content=评审和期刊编辑一般会询问什么问题？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586491, encodeId=22d15864910c, content=投稿后1个月给消息，小修后接受，按要求point to point回答了问题，润了色，现在返修半个多月了还是under review，估计是审稿人不满意，要凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca475278851, createdName=1483b36dm43(暂无昵称), createdTime=Fri Mar 13 00:40:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586490, encodeId=73b8586490a1, content=是美国的杂志不是德国的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca475278851, createdName=1483b36dm43(暂无昵称), createdTime=Fri Mar 13 00:36:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581076, encodeId=192c5810e6e7, content=online后多少时间正式发表<span class="quote">wind1060 2018-01-09 21:01:00 发表:<br>杂志不选open access的话不要版面费，编辑比较友好，审稿人的意见很专业，投的一篇文章一审用了两个月，给1个半月补实验修稿，补了一个实验，按照要求认真回答了问题，修回后又审了半个月接收了。接收后半个月左右收到proof，给2个工作日的时间proof，返回proof后第二天就online了，总体来说效率还是挺高的，德国人也确实挺负责。祝大家好运！</span>, beContent=wind1060 2018-01-09 21:01:00 发表: 杂志不选open access的话不要版面费，编辑比较友好，审稿人的意见很专业，投的一篇文章一审用了两个月，给1个半月补实验修稿，补了一个实验，按照要求认真回答了问题，修回后又审了半个月接收了。接收后半个月左右收到proof，给2个工作日的时间proof，返回proof后第二天就online了，总体来说效率还是挺高的，德国人也确实挺负责。祝大家好运！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=14e11602765, createdName=sxmlw, createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572522, encodeId=5d685e2522f0, content=哈哈 突破3分了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e641638819, createdName=eathon, createdTime=Thu Jun 20 21:32:00 CST 2019, time=2019-06-20, status=1, ipAttribution=)]
    2019-12-06 sxmlw

    online后多少时间正式发表wind1060 2018-01-09 21:01:00 发表:
    杂志不选open access的话不要版面费，编辑比较友好，审稿人的意见很专业，投的一篇文章一审用了两个月，给1个半月补实验修稿，补了一个实验，按照要求认真回答了问题，修回后又审了半个月接收了。接收后半个月左右收到proof，给2个工作日的时间proof，返回proof后第二天就online了，总体来说效率还是挺高的，德国人也确实挺负责。祝大家好运！

    wind1060 2018-01-09 21:01:00 发表: 杂志不选open access的话不要版面费，编辑比较友好，审稿人的意见很专业，投的一篇文章一审用了两个月，给1个半月补实验修稿，补了一个实验，按照要求认真回答了问题，修回后又审了半个月接收了。接收后半个月左右收到proof，给2个工作日的时间proof，返回proof后第二天就online了，总体来说效率还是挺高的，德国人也确实挺负责。祝大家好运！

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1088385, encodeId=4c2310883858a, content=评审要求我补充实验，可我的样品已经用完了/实验已经结束了，直接说我样本用完了会被拒稿么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150197, encodeId=e8d4215019edd, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：肿瘤;药理;化疗<br>经验分享：一篇小综述 第一次投稿三个星期了还是editor assigned，觉得太慢所以撤了稿。然后一直被其他的拒，所以后来又投这个。 第二次投稿 2023-05-17 submitted 2023-05-18 Reviewers Assigned（中途06-02变了时间） 2023-06-05 Under Review 2023-06-09 Reviewers Assigned（中途06-15，06-23，07-03，07-10变了时间） 2023-07-17 minor revision（给了十天小修时间，只有一个审稿人，编辑点了一下英语水平和摘要过于简短两处，我送去润了个色，23号返修回去了。然后因为格式有点问题，马上打回来了，24重新提交） 2023-07-24 Editor assigned 2023-07-27 Accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a75b8355868, createdName=ms3000002116358941, createdTime=Fri Jul 28 02:35:41 CST 2023, time=2023-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092071, encodeId=c1ff20920e159, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：癌症;药理<br>经验分享：一审很快，一周左右，小修一个半月，修回后半天就接受，效率杠杠的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3818221163, createdName=ms7000001575920827, createdTime=Thu Oct 06 13:40:45 CST 2022, time=2022-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218744, encodeId=88f51218e449f, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：肿瘤;化疗药<br>经验分享：8月底投稿，9月审稿意见补个小实验，11月再次提交然后一个星期内接收，12月底出版。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=19435556599, createdName=ms2000000730395477, createdTime=Wed May 11 14:51:09 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920655, encodeId=1fbc920655f0, content=审稿速度:3.0<br>偏重的研究方向：肿瘤;化疗<br>经验分享：请教一下大家，大修回去被拒的可能性大吗，按照审稿人意见修改的，审稿人意见挺好的，虽然给了大修，但是主要是修改讨论部分，大修意见也主要是提供一些审稿人自己的思路，我都加到讨论部分里面了，已经under review1周了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=559, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqSU0CLUujgLk4UUOR1ibG8ruibu1HpuH6icnUibmvdTBL2wVflfabqDQZWiaSe8zZ8gpchPXibGPcQotYw/132, createdBy=6c725325434, createdName=Y, createdTime=Thu Jan 28 10:04:30 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088386, encodeId=33d3108838606, content=评审和期刊编辑一般会询问什么问题？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586491, encodeId=22d15864910c, content=投稿后1个月给消息，小修后接受，按要求point to point回答了问题，润了色，现在返修半个多月了还是under review，估计是审稿人不满意，要凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca475278851, createdName=1483b36dm43(暂无昵称), createdTime=Fri Mar 13 00:40:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586490, encodeId=73b8586490a1, content=是美国的杂志不是德国的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca475278851, createdName=1483b36dm43(暂无昵称), createdTime=Fri Mar 13 00:36:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581076, encodeId=192c5810e6e7, content=online后多少时间正式发表<span class="quote">wind1060 2018-01-09 21:01:00 发表:<br>杂志不选open access的话不要版面费，编辑比较友好，审稿人的意见很专业，投的一篇文章一审用了两个月，给1个半月补实验修稿，补了一个实验，按照要求认真回答了问题，修回后又审了半个月接收了。接收后半个月左右收到proof，给2个工作日的时间proof，返回proof后第二天就online了，总体来说效率还是挺高的，德国人也确实挺负责。祝大家好运！</span>, beContent=wind1060 2018-01-09 21:01:00 发表: 杂志不选open access的话不要版面费，编辑比较友好，审稿人的意见很专业，投的一篇文章一审用了两个月，给1个半月补实验修稿，补了一个实验，按照要求认真回答了问题，修回后又审了半个月接收了。接收后半个月左右收到proof，给2个工作日的时间proof，返回proof后第二天就online了，总体来说效率还是挺高的，德国人也确实挺负责。祝大家好运！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=14e11602765, createdName=sxmlw, createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572522, encodeId=5d685e2522f0, content=哈哈 突破3分了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e641638819, createdName=eathon, createdTime=Thu Jun 20 21:32:00 CST 2019, time=2019-06-20, status=1, ipAttribution=)]
    2019-06-20 eathon

    哈哈 突破3分了

    0

共65条页码: 1/7页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map